OLD National Bancorp IN Purchases 441 Shares of Zoetis Inc. (NYSE:ZTS)

June 11, 2025

[ad_1]

OLD National Bancorp IN increased its position in shares of Zoetis Inc. (NYSE:ZTS – Free Report) by 28.4% during the first quarter, HoldingsChannel.com reports. The fund owned 1,993 shares of the company’s stock after acquiring an additional 441 shares during the period. OLD National Bancorp IN’s holdings in Zoetis were worth $328,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Atlantic Edge Private Wealth Management LLC increased its holdings in Zoetis by 482.8% during the 4th quarter. Atlantic Edge Private Wealth Management LLC now owns 169 shares of the company’s stock worth $28,000 after acquiring an additional 140 shares during the period. Rakuten Securities Inc. increased its holdings in Zoetis by 5,533.3% during the 4th quarter. Rakuten Securities Inc. now owns 169 shares of the company’s stock worth $28,000 after acquiring an additional 166 shares during the period. Navigoe LLC bought a new stake in Zoetis during the 4th quarter worth approximately $30,000. Murphy & Mullick Capital Management Corp bought a new position in shares of Zoetis in the 4th quarter worth $44,000. Finally, Asset Planning Inc bought a new position in shares of Zoetis in the 4th quarter worth $58,000. Institutional investors own 92.80% of the company’s stock.

Analysts Set New Price Targets

A number of equities analysts have recently commented on the stock. Barclays increased their price target on shares of Zoetis from $242.00 to $244.00 and gave the stock an “overweight” rating in a report on Friday, February 14th. Morgan Stanley decreased their price target on shares of Zoetis from $243.00 to $238.00 and set an “overweight” rating on the stock in a report on Friday, February 14th. Wall Street Zen raised shares of Zoetis from a “hold” rating to a “buy” rating in a report on Friday, March 7th. Piper Sandler increased their price target on shares of Zoetis from $205.00 to $210.00 and gave the stock an “overweight” rating in a report on Monday, May 12th. Finally, Stifel Nicolaus decreased their price target on shares of Zoetis from $180.00 to $165.00 and set a “buy” rating on the stock in a report on Monday, April 14th. One research analyst has rated the stock with a hold rating, eight have assigned a buy rating and two have issued a strong buy rating to the company’s stock. According to MarketBeat, Zoetis currently has a consensus rating of “Buy” and an average price target of $212.75.

Want More Great Investing Ideas?

View Our Latest Stock Report on ZTS

Zoetis Price Performance

Shares of Zoetis stock opened at $167.10 on Wednesday. Zoetis Inc. has a 52-week low of $139.70 and a 52-week high of $200.33. The stock has a market capitalization of $74.39 billion, a price-to-earnings ratio of 30.55, a price-to-earnings-growth ratio of 2.78 and a beta of 0.94. The company has a fifty day moving average of $157.58 and a 200-day moving average of $164.14. The company has a debt-to-equity ratio of 1.09, a quick ratio of 1.08 and a current ratio of 1.75.

Zoetis (NYSE:ZTS – Get Free Report) last announced its quarterly earnings data on Tuesday, May 6th. The company reported $1.48 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.40 by $0.08. Zoetis had a net margin of 26.86% and a return on equity of 53.82%. The company had revenue of $2.22 billion during the quarter, compared to analysts’ expectations of $2.20 billion. During the same quarter in the prior year, the company earned $1.38 EPS. The firm’s revenue was up 1.4% on a year-over-year basis. Equities research analysts expect that Zoetis Inc. will post 6.07 EPS for the current year.

Zoetis Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 3rd. Stockholders of record on Friday, July 18th will be paid a $0.50 dividend. The ex-dividend date of this dividend is Friday, July 18th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 1.20%. Zoetis’s dividend payout ratio (DPR) is 35.91%.

Insider Activity

In other Zoetis news, EVP Roxanne Lagano sold 652 shares of the stock in a transaction on Tuesday, June 3rd. The shares were sold at an average price of $170.00, for a total transaction of $110,840.00. Following the completion of the sale, the executive vice president now owns 15,129 shares of the company’s stock, valued at $2,571,930. This represents a 4.13% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website. 0.18% of the stock is owned by corporate insiders.

About Zoetis

(Free Report)

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.